Active ingredients: pemetrexed
What it is used for
Malignant Pleural Mesothelioma:,Pemetrexed-DRLA, in combination with cisplatin, is indicated for the treatment of patients with malignant,pleural mesothelioma.,Non-Small Cell lung Cancer:,Pemetrexed-DRLA in combination with cisplatin is indicated for initial treatment of patients with locally,advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,Pemetrexed-DRLA as monotherapy is indicated for the treatment of patients with locally advanced or,metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior,platinum-based chemotherapy.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store below 25 degrees Celsius
- Lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
Pemetrexed disodium for injection 500 mg/vial is a white to either light-yellow or green-yellow lyophilised powder packed in 50 mL glass vial with 20 mm rubber stopper and sealed with 20 mm aluminium flip-off seal
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient pemetrexed
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)